• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

作者信息

Iwata Shigeru, Saito Kazuyoshi, Yamaoka Kunihiro, Tsujimura Shizuyo, Nawata Masao, Suzuki Katsunori, Tanaka Yoshiya

出版信息

Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.

DOI:10.1093/rheumatology/kep126
PMID:19465589
Abstract
摘要

相似文献

1
Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.抗TNF-α抗体英夫利昔单抗治疗难治性肠白塞病的疗效
Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.
2
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.抗 TNF-α 抗体英夫利昔单抗联合甲氨蝶呤治疗难治性肠白塞病的疗效。
Mod Rheumatol. 2011 Apr;21(2):184-91. doi: 10.1007/s10165-010-0370-y. Epub 2010 Nov 5.
3
Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.使用肿瘤坏死因子-α阻滞剂英夫利昔单抗成功治疗难治性白塞病。
Iran J Immunol. 2009 Mar;6(1):55-8.
4
[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].[白塞病与现代肿瘤坏死因子抑制药物的应用可能性]
Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):705-9.
5
Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.早期治疗并接受支持使用抗TNF-α疗法治疗白塞氏葡萄膜炎的证据。
Br J Ophthalmol. 2010 Mar;94(3):269-70. doi: 10.1136/bjo.2009.176750.
6
Successful treatment of long-standing neuro-Behçet's disease with infliximab.英夫利昔单抗成功治疗长期神经白塞病。
J Rheumatol. 2005 Jan;32(1):181-3.
7
Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.阿达木单抗和英夫利昔单抗治疗难治性肠白塞病的真实世界疗效。
Dig Liver Dis. 2019 Jul;51(7):967-971. doi: 10.1016/j.dld.2018.10.024. Epub 2019 Feb 19.
8
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.抗TNF-α治疗白塞病所致难治性葡萄膜炎：124例患者的1年随访研究
Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.
9
Successful treatment of genital ulcers with infliximab in Behcet's disease.英夫利昔单抗成功治疗白塞病生殖器溃疡
Ann Rheum Dis. 2004 Jun;63(6):744-5. doi: 10.1136/ard.2003.010975.
10
Effect of infliximab on refractory uveitis in Behcet's disease.英夫利昔单抗对白塞病难治性葡萄膜炎的疗效。
Ann Pharmacother. 2004 May;38(5):901-2. doi: 10.1345/aph.1D361. Epub 2004 Mar 9.

引用本文的文献

1
Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet's disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study.阿达木单抗治疗韩国肠贝赫切特病患者的真实世界疗效和安全性：韩国肠病研究学会（KASID）多中心研究。
Korean J Intern Med. 2023 Sep;38(5):661-671. doi: 10.3904/kjim.2022.394. Epub 2023 Jul 26.
2
Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.成功使用Vedolizumab 治疗有肿瘤病史的难治性肠白塞病：病例报告及文献复习。
Front Immunol. 2023 May 23;14:1205046. doi: 10.3389/fimmu.2023.1205046. eCollection 2023.
3
Biologic treatments in Behçet's disease.
白塞病的生物治疗
Eur J Rheumatol. 2021 Oct;8(4):217-222. doi: 10.5152/eurjrheum.2020.20138.
4
Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.上海 Behcet 病数据库中初诊肠道 Behcet 病患者的不良预后因素：一项前瞻性队列研究。
Orphanet J Rare Dis. 2019 Nov 28;14(1):274. doi: 10.1186/s13023-019-1228-9.
5
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.难治性肠白塞病患者中单用皮质类固醇激素与 TNF 抑制剂联合或不联合皮质类固醇激素治疗的对比研究。
Arthritis Res Ther. 2019 Jun 22;21(1):151. doi: 10.1186/s13075-019-1933-8.
6
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.英夫利昔单抗与一名患有肠道和造血系统受累的白塞病患者的危及生命的肺部感染相关：一例报告。
Medicine (Baltimore). 2017 Dec;96(50):e9202. doi: 10.1097/MD.0000000000009202.
7
Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?肠道白塞病：一种真正的炎症性肠病还是仅仅是系统性血管炎的肠道并发症？
Yonsei Med J. 2016 Jan;57(1):22-32. doi: 10.3349/ymj.2016.57.1.22.
8
Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.阿达木单抗治疗一名难治性肠白塞病女孩的疗效
Case Rep Rheumatol. 2015;2015:716138. doi: 10.1155/2015/716138. Epub 2015 Nov 2.
9
Gastrointestinal Behçet's disease: a review.胃肠道白塞病：综述
World J Gastroenterol. 2015 Apr 7;21(13):3801-12. doi: 10.3748/wjg.v21.i13.3801.
10
Anti-TNF-alpha therapy and systemic vasculitis.抗肿瘤坏死因子-α治疗与系统性血管炎
Mediators Inflamm. 2014;2014:493593. doi: 10.1155/2014/493593. Epub 2014 Feb 27.